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1079-l 30 Evidence for Association of the Glu298Asp and T786C 
Polymorphisms of the Endothehal Nitric Oxide 
Synthase Gene to the Presence and Severity of 
Coronary Artery Disease 
Mana Glowanna Colombo, Maria Grazia Andreassi, Nlcoletta Botto, Samantha Manfredl. 
Serena Masetti. Umbedo Paradossi, Aldo Clerico, Andrea Biagini. CNR, Institute of 
Clinical Physiology, G. Pasquinucci Hospital, Massa, Italy 
Background: Genetic variants of the endothelial Nitric Oxide Synthase(eNOS) could 
influence individual susceptibility to coronary artery disease (CAD). 
Objecwe: This study investigated the relationship of the eNOS Glu298Asp and T786C 
polymorphisms, both alone and in combination, to the presence and severity of CAD in 
the Italian population. 
Methods We analyzed the eNOS Glu298Asp and T786C variants In 415 and 374, 
respectwely. unrelated subjects who underwent coronary angiography. The severity of 
CA0 was expressed by means of the Duke sconng system. 
Results: There was significant linkage disequilibrium between the two eNOS gene poly- 
morphlsms (pcO.0001). The Glu298Asp variant was significantly associated with the 
occurrence (~~0.03) and severity of CAD (p=O.Ol). The T786C polymorphism was signlf- 
icantly associated with the presence (p=O.O2) and with the extent and severity of CAD 
(39.6-t2.9, 38.1k2.2 and 27.3+2.8 for CC786 TC786 and TT786, raSpaCtivsly; p=O.O04). 
The risk of CAD was increased among CC786 carriers in comparison to homozygous 
subjects for the T786 allele (OR 2.5; ~~0.01) and was Independent from the other com- 
mon risk factors (p=O.O4). Moreover, carriers of both Asp/Asp298 and at least one C786 
allele were at higher risk of CAD than carriers of single genotypes (OR 4.0 for Asp/Asp 
and C786 allele simultaneously carriers vs 2.6 and 1.7 for Asp/Asp and for C786 allele, 
respectively). 
Conclusions: The Glu298Asp and the T786C polymorphisms of the eNOS gene are 
associated with the presence, extent and severity of CAD in the ltallan population. 
1079-131 The A376G (A+) Variant of the Glucose-B-Phosphate 
Dehydrogenase Gene Is Associated With Endothelial 
Dysfunction in African Americans 
Marc A. Forqione, Joseph Loscalzo. Monica Holbrook, Rowlens Melduni, Joseph 
Palmisano, Carolyn Maxwell, Clinton Baldwin, Joseph A. Vita, Boston University School 
of Medicine, Boston, MA 
Glucose-6-phosphate dehydrogenase (GGPD) is the primary source of NADPH in cells. 
GGPD deficiency is an X-linked enzymopathy that occurs in -11% of African Americans 
and is commonly due to an A to G point mutation at position 376 (A+ variant) or due to a 
mutation at this position combined with one of three other mutations (A- variant). GGPD 
defiwancy is associated with oxidant-Induced hemolyiic anemia and increased oxidant 
stress, however the vascular consequences of GGPD deficiency are unknown. Since 
NADPH serves as an essential cofactor for several antioxidant enzymes and nitric oxide 
synthase, we hypothesized that GGPD deficiency would be associated with endothelial 
dysfunction. We genotyped the GGPO gene in healthy African Americans and identified 
10 hemizyogous men and 8 heterozygous women with the A378G mutation and 34 unaf- 
fected age-matched subjects (16 men and 18 women). As shown (Table) brachial artery 
flow-mediated dilation was impaired in men with the A+ variant compared to unaffected 
men. There was a trend for reduced red blood cell GGPD activity (assessed as time to 
NADPH-dependent dichlorophenol indophenol reduction) in the A+ variant men (64+39 
min) compared to unaffected men (41~12 min, P = 0.096). Flow-mediated and nitroglyc- 
enn-mediated dilation and GGPO activity were similar in heterozygous and unaffected 
women. Thus, the A+ variant is associated wth impairment in the blological activity of 
nitric oxide and may contribute to increased cardiovascular disease risk in African Amer- 
icans. 
Table. Effect of A376G Mutatron on Vascular Function m African American Malea 
Normal 
(n=16) 
Flow-mediated ilation (%) 12.8t6.7 
Flow-mediated ilation (mm) 0.53+0.21 
Nitroglycerin-mediated dilation (%) 22.0*9.7 
A+ Variant 
(n=lO) 
5.3*4.5 
0.17kO.21 
15.7e6.0 
P 
0.004 
0.001 
0.13 
1079-132 Polymorphisms of the CETP, ABC, MTHFR, LPL, and 
PAI-I Genes Predict Intermediate Endpoints but Not 
Angiographic Coronary Disease: Implications for 
Genetic Research 
Beniamun 0. Home, Jeffrey L. Anderson, Joseph B. Muhlestein. Bryant M. Whiting, Tami 
L. Bair, Robert R. Pearson, John F. Carlqulst, LDS Hospital, Salt Lake City, UT, 
University of Utah, Salt Lake City, UT 
Background: Moderate-wed studies show that common functional variants of candi- 
date genes predict intermediate phenotypes for coronary artery disease (CAD), but 
whether those results are an efficient surrogate for predicting clinical CAD is unknown. 
We studied a single nucleotide polymorphism (SNP) from each of five candidate genes 
as a predictor of intermediate (laboratory) and clinical endpoints (angiographic CAD). 
Methods Patients in the Registry of the lntermountam Heart Collaboratwe Study were 
genotypad for 5 SNPs: cholestery ester transfer protein (CETP) TadB (N=3,391), ATP- 
binding Cassette (ABC) G596A (N-3,279). methylenetetrahydrofolate (MTHFR) C677T 
(N=731), IipOprOtein lipase (LPL) Hinolll (N=l,Oil), and plasminogen actwator Inhibitor 
(PAI)-i 4Gl5G (N=1,246). Intermediate outcomes included high-density lipoprotein 
(HDL), triglycerides (TG), or total homocysteine (tHCY). Cases had 1-3 vessel CAD 
(270% stenosis): controls had angiographically normal coronaries. Adjustment was made 
for age, sex, and CAD nsk factors. 
Results: Average age was 64+12 years, 69% were male. CETP predlcted HDL (mean: 
BlB1=34.8, BiB2=36.6, B282=38.4 mg/dL; p=O.OOl) but not CAD (81: 75%, 8262: 
71%; ~~0.22, odds ratio [OR]=1.15). ABC predlcted HDL (mean: GG=36.5. GAz35.9, 
AA=38.0 mg/dL; ~~0.07) but not CAD (GG: 74% A: 75%; ~~0.65, OKl.04). MTHFR 
predicted tHCY (median. CG=13.1, CT=13.3, TT=14.4 pmol/L; p=O.O2) but not CAD (C: 
79%, TT: 77%; ~~0.66, OR~0.88). LPL predicted TG (median: [--1 98, [-+] 124, [++] 134 
mg/dL; p=O.O2) but not CAD (I-1 78% [++] 78%; p=O.93. OR=0.99). PAI- predicted TG 
(median: 4G4G=130, 4G5G=137, 5G5G=148 mg/dL; p=O.O02) but not CAD (4G: 77% 
5G5G: 78%; p=O.79, OR=0.98). 
Conclusions: Five SNPs predicted differences in risk-related lipids or tHCY, but not 
angiographic CAD. The discrepancies between Intermediate and cllnical phenotypes 
suggest that common polygenic factors modulate the clinical risk associated with candi- 
date genes’ susceptibility variants. Studies of haplotypes (rather than SNPs), multiple 
interacting genes, and associations to clinical (rather than mtermediate) phenotypes may 
be necessary to unravel the complex genetic basis of CAD. 
1079-l 33 Murine Cytomegalovirus Infection Increases Aortic 
Expression of Proatherosclerotic Genes 
Marv Susan Burnett Sarfraz A. Durranl, Motoyasu Saji, Cindy Gulick, Eric P. Hoffman, 
Stephen E. Epstein, MedStar Research Institute, Washington, DC, Children’s Natlonal 
Medical Center, Washington, DC 
Background: Results in several recent antibiotic trials raise questions as to the possible 
role of infections in cardiovascular disease. While these findings suggest that bacterial 
InfectIons sensitive lo the antIbIotic administered may not contribute to an increase in 
cardiovascular events, these studies do not test the potential role of viral and non-sensi- 
tive bacterial infections in disease progression. Murine cytomegalovirus (MCMV) infec- 
tion of apoE -/- mice increases atherosclerotic lesion size. In this study gene arrays were 
used to determine if MCMV infection produces atherogenic changes in aortic gene 
expression. 
Methods: ApoE -/- mice were infected with 30,000 PFU of MCMV; a second group was 
gven an uninfected cell supematant. One week post infection, aortas were collected and 
pooled. Total RNA was extracted and reverse transcribed into double stranded cDNA. 
Labeled cRNA was hybridized to Affymetrix murine U74A chips. Data were analyzed 
using Microarray Suite software. 
Results: MCMV Infection changed aortic gene expression in the apoE -I- mice. Of the 
100 genes that were differentially expressed, 25% are involved in mflammation/immune 
responses. Three genes, encoding MCP-1, IP-10 and MIG, are known to be proathero- 
sclerotic and may predispose to plaque destabilization. These molecules are active In 
monocyte and T cell recruitment, and induce T cell adherence to endothellal cells. The 
-10 fold increase in expression levels observed for these genes was confirmed in a sep- 
arate group of animals, by western blotting, or TaqMan PCR. 
Conclusions: In the apoE -/- aorta, MCMV infection significantly increases expression of 
three genes: MCP-I, IP-IO. and MIG,known to play important roles in atherogenesis, and 
perhaps plaque destabilization. These infection-induced effects indicate a possible 
mechanism by which pathogens and the immune/inflammatory responses they elicit con- 
tribute to atherosclerotic disease Initiation, progresslo”, and precipitation of complicating 
clinical events. These results also emphasize that the negative results of macollde anti- 
biotic trials are not relevant to potential atherogenic effects of pathogens not sensitive lo 
these therapeutic agents. 
1079-l 34 Interactive Effect of the Glutathione S-Transferase Null 
Genotypes Ml and Tl and Cigarette Smoking on 
Coronary Artery Disease Risk and DNA Damage 
Serena Masetti, Nlcoletta Botto, Samantha Manfredi, Maria Giovanna Colombo, Antonio 
Rizza, Aldo Cler~co. Andrea Biagmi,Mana Grazia Andreassi, CNR. lnstltute of Clinical 
Physiology, G. Pasqulnucci Hospital, Massa, Italy 
Background: It has been suggested that cancer and altherosclerosls might share a com- 
mon etiology. GSTS polymorphisms, which are associated with Increased cancer risk, 
may be important in modulating susceptibility to CAD. 
Aim: to evaluate Glutathione S-transferases (GSTs) null Ml and Tl (GSTMI and 
GSTTl) genotypes as susceptibility genetic risk factors for coronary artery disease 
(CAD) and DNA damage. 
Methods: We studied 430 patients who underwent coronary anglography, and examined 
the levels of DNA damage in 80 male patbents by the micronucleus (MN) test, a sensitive 
assay for evaluatmg DNA damage. 
Results: The frequencies of GSTs null genotypes in 308 patients with CAD were not sig- 
nlflcantly different from those of 122 patients without CAD We observed, however, that 
GSTs null genotypes are associated with the occurrence of CAD among smokers (odds 
ratios (OR) and 95% confidence interval (Cl) were OR= 2.2, Cl 95%= 1.2-4.2. p=O.Oi; 
OR= 3.4, Cl 95%= 1.6-7.1. p=O.OOl; OR= 4.0, Cl 95%= 1.4-11.5. p=O.Ol. for smokers 
with null GSTMl, GSnl and both null genes as compared to never smokers with the 
present GSTs genotypes, respectively) There was a significant association between 
smoker null genotypes and both the number of stenosed vessels chi squarec7.6, p=O.O5; 
chi square =13.7, p=O.O003; chi square =lO.O. p=O.O2. for GSTMl, GSTTl and both 
genes, respectwely) and the Duke score (p= 0.03; p=O.O002; p=O.O04, for GSTMl, 
GSTTI end both genes, respectively) as compared to non-smokers patients expressing 
the genes. 
MN levels were sigmficantly higher in smokers null GSTs individuals as compared to 
smokers with present GSTs genes (p=O.O04; p=O.O07; p=O.O02, for GSTMl GSTTl and 
both genes. respectively). 
Conclusion: These observations suggest that GSTs-null genotypes strenghten the effect 
of smoking on CA0 risk, likely by modulating the detoxification of genotoxlc atherogens. 
